Teriparatide (human parathyroid hormone (1-34)) inhibits osteogenic vascular calcification in diabetic low density lipoprotein receptor-deficient mice.
about
Mechanisms of arterial calcifications and consequences for cardiovascular functionArterial calcification in chronic kidney disease: key roles for calcium and phosphateVascular calcification: pathobiology of a multifaceted diseaseCalcific aortic valve stenosis: methods, models, and mechanismsHyperlipidemia impairs osteoanabolic effects of PTH.Inflammation and the osteogenic regulation of vascular calcification: a review and perspective.Parathyroid hormone: critical bridge between bone metabolism and cardiovascular disease.Should teriparatide ever be used for adynamic bone disease?Effect of race and genetics on vitamin D metabolism, bone and vascular health.The bone-vascular axis in chronic kidney disease.Atherogenic phospholipids attenuate osteogenic signaling by BMP-2 and parathyroid hormone in osteoblasts.Spatial heterogeneity of endothelial phenotypes correlates with side-specific vulnerability to calcification in normal porcine aortic valves.Ankle-brachial index and bone turnover in patients on dialysisThe roles of lipid oxidation products and receptor activator of nuclear factor-κB signaling in atherosclerotic calcificationSerum Dickkopf-1 signaling and calcium deposition in aortic valve are significantly related to the presence of concomitant coronary atherosclerosis in patients with symptomatic calcified aortic stenosisMechanisms linking osteoporosis with cardiovascular calcification.Osteogenic regulation of vascular calcification: an early perspective.Why do dialysis patients develop a heart of stone and bone of china?Parathyroid hormone and leptin--new peptides, expanding clinical prospects.Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies.Arterial calcification and bone physiology: role of the bone-vascular axis.PTH(1-84)/PTH(7-84): a balance of power.Role of matrix Gla protein in parathyroid hormone inhibition of osteoblast mineralization.Osteogenic regulation of vascular calcification.The mechanism of vascular calcification - a systematic review.Role of osteoprotegerin and its ligands and competing receptors in atherosclerotic calcification.Msx2 exerts bone anabolism via canonical Wnt signaling.Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.Osteopontin promoter polymorphism is associated with increased carotid intima-media thicknessVascular calcification and arterial stiffness in chronic kidney disease: implications and management.Phosphate and pyrophosphate mediate PKA-induced vascular cell calcificationGlucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralizationOsteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) mice.PTH and PTHrP signaling in osteoblastsLowering vascular calcification burden in chronic kidney disease: Is it possible?The pathogenesis of vascular calcification in the chronic kidney disease mineral bone disorder: the links between bone and the vasculature.The Strategy to Prevent and Regress the Vascular Calcification in Dialysis Patients.Association between Parathyroid Hormone, 25 (OH) Vitamin D, and Chronic Kidney Disease: A Population-Based Study.The regulation of valvular and vascular sclerosis by osteogenic morphogensChronic kidney disease and vascular remodelling: molecular mechanisms and clinical implications.
P2860
Q26821993-FDE54CA9-AF3D-4C67-815D-58F0E2355359Q26827655-B18C8EFC-5685-422E-AD45-FF2CD164B7E6Q28282418-26C5611E-08B7-419B-B607-06474CF08031Q30503246-CD1BE998-153C-4E4F-A321-A24070DD9B4BQ33337922-FC7A80DF-BD5E-4522-B545-C625DEF9A822Q33782750-209C75AA-1001-4B80-9115-32AC8FEE1038Q33889235-D2FF10D2-C2ED-4C56-919D-4E096F145B13Q33995995-679ADB14-89E9-4B30-AD87-8CF8CF40936DQ34280570-1A18BAAC-2412-4954-9E1F-D14DA00F0BD8Q34402808-F97A696B-14C8-42B2-AF5B-D59A768EA073Q34402832-8EB6C962-F458-4C05-BB90-8076E9975420Q34670503-763D3735-4D3D-4806-AFF0-BAD77FA86679Q35027284-562D6D3E-F206-4A60-AF10-873297406217Q35083231-D0709849-921E-481E-9447-A77611E84317Q35107730-FF0F2222-31AC-4BD2-9207-972E82DF45F5Q35575965-E4958067-0C3D-4D29-B0FC-389E0F59858EQ35753562-C77A4734-626B-4A4F-AF0B-B8C5C639FA26Q36089002-C95AD8A1-345B-4B22-B4D0-610232D23BE6Q36099410-C25AEF08-40BB-4733-97A1-A182789F4573Q36162995-496CF580-F214-4530-87C9-277D7899B6AFQ36177303-5191DE79-4ACF-4DC4-9E79-22B41B9C17D8Q36443039-ADA4885F-E430-4C88-81C2-5FB94E856796Q36447968-AC871CEF-6837-4127-9E92-4BB699FC04FFQ36532553-65306A0D-939B-40D5-9E07-9DC3C853B561Q36577167-6950DBAE-8BD0-4C8F-83F3-14C15C5BF362Q36684209-E7D7BA97-AFF0-42A7-A79F-EE326C55BB59Q36761867-3AD3A581-B656-42C6-BCB9-C923B473F57DQ36860987-4F56DEB1-9915-4AA2-B5DE-322E51159B82Q36876644-D2EC7109-F879-484D-AF57-F86F9A1AC594Q36930927-A3E06500-3EAB-490E-A438-90BD3CB78597Q36943228-803146C5-EDBD-4D39-AB85-C62AA32918A4Q37003240-7AC7AC0C-0FD9-40EC-A038-567968D1C4FCQ37188485-1693A5E6-F663-4FF3-A69C-7641F934B307Q37297529-18AA4F63-930B-4E60-845E-4232421FF79DQ37322136-10E1B975-481D-4547-977C-4A19CFEB4656Q37446201-0ADF9D57-86E3-410A-9E23-3E8C34D058B8Q37670856-1BF87B74-E52F-45E0-BC78-6ED4BEAFD215Q37712804-5BDCC1C7-5E38-41E6-8D19-41EBE73934F9Q37919693-BA1BE22A-D1D7-41E6-BAA0-6856A8C206B4Q38016491-CE70E621-9C2A-45C8-8EB1-D30D1B27E7C3
P2860
Teriparatide (human parathyroid hormone (1-34)) inhibits osteogenic vascular calcification in diabetic low density lipoprotein receptor-deficient mice.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Teriparatide (human parathyroi ...... otein receptor-deficient mice.
@en
type
label
Teriparatide (human parathyroi ...... otein receptor-deficient mice.
@en
prefLabel
Teriparatide (human parathyroi ...... otein receptor-deficient mice.
@en
P2093
P2860
P356
P1476
Teriparatide (human parathyroi ...... otein receptor-deficient mice.
@en
P2093
Arleen P Loewy
Jian-Su Shao
Nichole Charlton-Kachigian
Su-Li Cheng
P2860
P304
50195-50202
P356
10.1074/JBC.M308825200
P407
P577
2003-09-22T00:00:00Z